Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Takotsubo cannot be diagnosed safely from the story or ECG alone. New chest pain, ST change, shock or malignant arrhythmia follows the emergency ACS pathway until coronary occlusion and other lethal alternatives are excluded.
Synopsis
Treat the initial ACS mimic safely, confirm transient non-coronary-pattern dysfunction and manage obstruction, shock and thromboembolism.
Takotsubo is transient LV and/or RV dysfunction, often beyond one coronary territory, after emotional, physical or neurological stress—but a trigger is not required.
It commonly affects postmenopausal women but can occur in any adult; do not use demographics to dismiss ACS.
ECG changes and troponin rise are common; coronary angiography is often needed because MI remains the immediate competing diagnosis.
Serial ECG and high-sensitivity troponinFirst step
Run the ACS pathway and identify evolving repolarisation/QT risk.
Management branches
Front doorPossible Takotsubo
Acute chest pain/dyspnoea with ECG change or troponin rise.
Activate the ACS pathway: ABCDE, ECG within 10 minutes, troponin, monitoring, aspirin if not contraindicated and immediate reperfusion assessment when indicated.
Obtain urgent echo but do not use a ballooning pattern to delay coronary angiography in an unstable or STEMI-pattern presentation.
RecoveryDischarge and confirmation
Stable after acute complications are controlled.
Key medicines
Aspirin300 mg orally once as soon as possible for suspected ACS, unless contraindicated; maintenance depends on the final coronary diagnosis.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.